Upon the failure of immunotherapy, the ANO1 gene is upregulated, activating the PI3K-Akt pathway, resulting in the expression of NRF2/SLC7A11 proteins and inhibiting oxidative stress in tumor cells. Here, SLC7A11 is linked to neoplasm.